$211 Million is the total value of Nan Fung Group Holdings Ltd's 45 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 225.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SGEN | Buy | SEAGEN INC | $6,784,000 | -3.2% | 47,096 | +3.9% | 3.22% | +55.1% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $2,267,000 | -25.3% | 12,022 | +7.3% | 1.08% | +19.7% |
| OTIC | Buy | OTONOMY INC | $2,043,000 | +15.4% | 851,080 | +0.0% | 0.97% | +84.9% |
| New | ENTRADA THERAPEUTICS INC | $1,630,000 | – | 173,582 | +100.0% | 0.77% | – | |
| REPL | New | REPLIMUNE GROUP INC | $1,265,000 | – | 74,479 | +100.0% | 0.60% | – |
| CCXI | New | CHEMOCENTRYX INC | $898,000 | – | 35,830 | +100.0% | 0.43% | – |
| New | 2SEVENTY BIO INC | $687,000 | – | 40,273 | +100.0% | 0.33% | – | |
| AFMD | New | AFFIMED N V | $355,000 | – | 81,172 | +100.0% | 0.17% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $306,000 | – | 3,917 | +100.0% | 0.14% | – |
| FGEN | New | FIBROGEN INC | $177,000 | – | 14,756 | +100.0% | 0.08% | – |
| KOD | Buy | KODIAK SCIENCES INC | $151,000 | -86.7% | 19,622 | +46.0% | 0.07% | -78.6% |
| CERS | New | CERUS CORP | $78,000 | – | 14,172 | +100.0% | 0.04% | – |
| TCRR | New | TCR2 THERAPEUTICS INC | $53,000 | – | 19,335 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| KARUNA THERAPEUTICS INC | 10 | Q3 2023 | 34.7% |
| HARMONY BIOSCIENCES HLDGS IN | 10 | Q3 2023 | 21.3% |
| XENON PHARMACEUTICALS INC | 10 | Q3 2023 | 3.1% |
| BOLT BIOTHERAPEUTICS INC | 10 | Q3 2023 | 5.6% |
| GALERA THERAPEUTICS INC | 10 | Q3 2023 | 1.9% |
| KALVISTA PHARMACEUTICALS INC | 10 | Q3 2023 | 1.8% |
| EXELIXIS INC | 10 | Q3 2023 | 1.1% |
| DBV TECHNOLOGIES S A | 10 | Q3 2023 | 0.6% |
| ALX ONCOLOGY HLDGS INC | 10 | Q3 2023 | 1.0% |
| ILLUMINA INC | 9 | Q3 2023 | 21.5% |
View Nan Fung Group Holdings Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Eargo, Inc. | December 16, 2022 | 2,958,099 | 0.7% |
| Stealth BioTherapeutics Corp | January 09, 2020 | 20,240,817 | 4.8% |
| New Frontier Health Corp | January 02, 2020 | 9,650,000 | 7.3% |
View Nan Fung Group Holdings Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-16 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Nan Fung Group Holdings Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.